Skip to the page

Data / Form D filings / AI Proteins, Inc.

AI Proteins, Inc.: Form D filings

AI Proteins, Inc., a biotechnology company in Boston, MA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on April 4, 2024, reports $5 million sold of a $10 million offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
20 OVERLAND STREET, Boston, MA, 02215
Phone
(617) 412-6117
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1903127

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 4, 2024New notice$10,000,000$4,995,000$5,005,0008Mar 21, 2024sec.gov
Aug 4, 2023New notice$10,000,000$8,300,000$1,700,0007Jul 21, 2023sec.gov
Jan 21, 2022New notice$18,205,000$11,321,003$6,883,99738Jan 11, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Bobby SandageDirector
Julia A. NovinaExecutive Officer
Chris BahlExecutive Officer, Director
Bruce EvansDirector
Drew DennisonDirector
Wendy DwyerExecutive Officer
Todd KaloudisDirector
Noah BeermanExecutive Officer, Director
Malcolm SalterDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Apr 1, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what AI Proteins, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.